CRISPR Therapeutics AG
CRSP
Market Cap$3.82B
Close$
$-3.79
108% downside
Current Fair Value
108% downsideOvervalued by 108% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.82 Billion |
|---|---|
| Enterprise Value | $3.81 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.34 |
| Beta | 1.74 |
| Outstanding Shares | 85,938,720 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.86 |
|---|---|
| PEG | -59.25 |
| Price to Sales | - |
| Price to Book Ratio | 2.27 |
| Enterprise Value to Revenue | 105.49 |
| Enterprise Value to EBIT | -7.95 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni